Axogen, Inc. — Director's Dealing 2013

Apr 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2013-01-01

Reporting Person: Rudelius Robert James (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-01	Stock Option (right to buy)	$2.75	A	13000	Acquired	2020-01-01	Common Stock (13000)	Direct

Footnotes

F1: Annual option grant as compensation for service on the board of directors. All options vested on the date of grant.